High-sensitivity cardiac troponin assays: Isn't it time for equality?

Clinical Chemistry

Volumn 60, Issue 1, 2014, Pages 7-9

  Jaffe, Allan S ^a   Apple, Fred S ^b,c  

^a MAYO CLINIC   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; TROPONIN T;

BLOOD CLOT LYSIS; CARDIAC MARKER CLIA KIT; CARDIAC TROPONIN 1 CLIA KIT; CARDIAC TROPONIN T ASSAY; EDITORIAL; EMERGENCY WARD; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PREDICTIVE VALUE;

EID: 84891797308     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.217927     Document Type: Editorial

References (15)

1. Akhter N, Milford-Beland S, Roe MT, Piana RN, Kao J, Shroff A, on behalf of the American College of Cardiology-National Cardiovascular Data Registry Investigators. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J 2009;157: 141-8.
2. Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz JM. Gender differences in management and outcomes in patients with acute 27 coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart 2007;93: 1369-75. (Pubitemid 351484789)
3. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005;45: 832-7. (Pubitemid 40347306)
4. Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation 2004;109: 580-6. (Pubitemid 38198864)
5. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003;49: 1331-6. (Pubitemid 36900619)
6. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58: 1574-81.
7. Laufer EM, Mingels AM, Winkens MH, Joosen IAPG, Schellings MWM, Leiner T, et al. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol 2010;30: 1269-75.
8. Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, Hallas J, Thygesen K, Mickley H. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126: 789-97.
9. Bohula May EA, Bonaca MP, Jarolim P, Antman EM, Braunwald E, Giugliano RP, et al. Prognostic performance of a high-sensitivity troponin I assay in patients with non-ST-elevation acute coronary syndrome. Clin Chem 2013;60: 158-64.
10. Kavsak PA, Shortt C, Pond G, Worster A. High-sensitivity cardiac troponin I for predicting death in a female emergency department population. Clin Chem 2013;60: 271-3.
11. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56: 254-61.
12. Mills NL, Lee KK, McAllister DA, Churchhouse AM, MacLeod M, Stoddart M, et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ 2012;344:e1533.
13. Shah ASV, Griffiths M, Lee KK, McAlister DA, Hunter AL, Cruikshank A, et al, on behalf of High-STEACS Investigators. High-sensitivity cardiac troponin and the under diagnosis of myocardial infarction in women [Abstract]. European Society of Cardiology Congress Report; 2013. http://www.escardio. org/congresses/esc-2013/congress-reports/Pages/711-High-STEACS.aspx#. Uon-bvkqiSo (Accessed November 2013).
14. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality in the general population. JAMA 2010;304: 2503-12.
15. Santalo M, Velilla MA, Povar J, Temboury F, Balaguer J, Munoz M, et al. Using high-sensitivity troponin T: the importance of the proper gold standard. Am J Med 2013;126: 709-17.